Search research articles
Contact Us
Filters
Showing results (521-530 of 609) with videos related to
Page
of 61
Sort By:
Antimicrobial Agents and Chemotherapy
|
August 4, 2022
Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model
Kamrul Islam, Fekade B Sime, Steven C Wallis, et al.
International Journal of Antimicrobial Agents
|
March 14, 2017
Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial
Andrew A Udy, Joel M Dulhunty, Jason A Roberts, et al.
International Journal of Antimicrobial Agents
|
May 11, 2024
Antimicrobial therapeutic drug monitoring in critically ill adult patients - An international perspective on access, utilisation, and barriers
Paul Williams, Menino Osbert Cotta, Alexis Tabah, et al.
Anaesthesia, Critical Care & Pain Medicine
|
April 26, 2022
Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)
Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
August 16, 2013
A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study
Joel M Dulhunty, Jason A Roberts, Joshua S Davis, et al.
Clinical Pharmacology and Therapeutics
|
February 8, 2021
Model-Informed Drug Development for Anti-Infectives: State of the Art and Future
Craig R Rayner, Patrick F Smith, David Andes, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
November 1, 2017
Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation
Fabrice Sinnah, Kiran Shekar, Mohd H Abdul-Aziz, et al.
Critical Care (London, England)
|
June 18, 2023
International survey of antibiotic dosing and monitoring in adult intensive care units
Paul G Williams, Alexis Tabah, Menino Osbert Cotta, et al.
The Journal of Antimicrobial Chemotherapy
|
October 5, 2015
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
Mohd H Abdul-Aziz, Jeffrey Lipman, Murat Akova, et al.
The Lancet. Infectious Diseases
|
April 29, 2014
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A Roberts, Mohd H Abdul-Aziz, Jeffrey Lipman, et al.
Page
of 61
Search research articles
Search
Showing results (521-530 of 609) with videos related to
Sort By:
Page
of 61
Antimicrobial Agents and Chemotherapy
|
August 4, 2022
Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model
Kamrul Islam, Fekade B Sime, Steven C Wallis, et al.
International Journal of Antimicrobial Agents
|
March 14, 2017
Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial
Andrew A Udy, Joel M Dulhunty, Jason A Roberts, et al.
International Journal of Antimicrobial Agents
|
May 11, 2024
Antimicrobial therapeutic drug monitoring in critically ill adult patients - An international perspective on access, utilisation, and barriers
Paul Williams, Menino Osbert Cotta, Alexis Tabah, et al.
Anaesthesia, Critical Care & Pain Medicine
|
April 26, 2022
Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)
Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
August 16, 2013
A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study
Joel M Dulhunty, Jason A Roberts, Joshua S Davis, et al.
Clinical Pharmacology and Therapeutics
|
February 8, 2021
Model-Informed Drug Development for Anti-Infectives: State of the Art and Future
Craig R Rayner, Patrick F Smith, David Andes, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
November 1, 2017
Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation
Fabrice Sinnah, Kiran Shekar, Mohd H Abdul-Aziz, et al.
Critical Care (London, England)
|
June 18, 2023
International survey of antibiotic dosing and monitoring in adult intensive care units
Paul G Williams, Alexis Tabah, Menino Osbert Cotta, et al.
The Journal of Antimicrobial Chemotherapy
|
October 5, 2015
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
Mohd H Abdul-Aziz, Jeffrey Lipman, Murat Akova, et al.
The Lancet. Infectious Diseases
|
April 29, 2014
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A Roberts, Mohd H Abdul-Aziz, Jeffrey Lipman, et al.
Page
of 61